218
Last Update Posted: 2017-01-12
Recruiting has ended
Females accepted | 18 Years-60 Years |
353 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Pharmacotherapy and Intensive Treatment - 2
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Eligibility
Relevant conditions:
Cocaine-Related Disorders
Substance-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov